Skip to main content
Erschienen in: Supportive Care in Cancer 4/2017

30.12.2016 | Original Article

Factors supporting cardiomyopathy screening among at-risk adult survivors of pediatric malignancies

verfasst von: Cheryl L. Cox, Liang Zhu, Rohit P. Ojha, Brenda D. Steen, Susan Ogg, Leslie L. Robison, Melissa M. Hudson

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Anthracyclines and chest irradiation place adult survivors of childhood cancer at risk of cardiomyopathy; many survivors do not obtain the recommended screening. Based on our recent clinical trial, the addition of telephone counseling to a printed survivorship care plan more than doubled survivors’ risk-based screening. Here, we sought to measure the impact of specific factors targeted in the intervention for their impact on survivors’ screening participation.

Methods

Study population—survivors participating in a randomized longitudinal intervention trial. Survivor questionnaires and medical records at baseline and 1-year follow-up provided the data. Within- and between-group differences in factors were assessed at baseline and follow-up; structural equation modeling (SEM) identified direct and indirect effects on screening participation.

Results

Of the 411 survivors, 55.3% were female, 89.3% white, 38.9% college graduates, and age 26–59 years (mean = 41 years, SD = 7.68 years). At follow-up, the counseling group demonstrated higher scores for intent to undergo screening (p < 0.001), adherence determination (p < 0.001), autonomous regulation (p < 0.001), competency (p = 0.03), perceived effort warranted for screening (p < 0.001), and perceived value of screening (p = 0.02). SEM identified four factors that directly influenced screening participation (n = 411, RMSEA = 0.02 [90% CI = 0.000–0.05]; CFI = 0.99; TLI = 0.99; WRMR = 0.63): the counseling intervention (p < 0.0001), intrinsic motivation (p < 0.0001), competency (p < 0.0001), and decisional control (p = 0.001); intrinsic motivation was also a mediator (p = 0.002) of screening participation.

Conclusions

Direct interpersonal interaction that focused on multiple modifiable, autonomy-supportive factors powerfully enhances the efficacy of a print survivorship care plan in increasing survivors’ screening participation. This finding challenges providers to reach beyond the disease treatment focus and embrace these strategies in their behavior change efforts.
Literatur
1.
Zurück zum Zitat Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, Hudson MM, Kremer LC, Landy DC, Miller TL, Oeffinger KC, Rosenthal DN, Sable CA, Sallan SE, Singh GK, Steinberger J, Cochran TR, Wilkinson JD, American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Radiolo (2013) Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation 128(19):e394. doi:10.1161/CIR.0b013e3182a88099 CrossRef Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, Hudson MM, Kremer LC, Landy DC, Miller TL, Oeffinger KC, Rosenthal DN, Sable CA, Sallan SE, Singh GK, Steinberger J, Cochran TR, Wilkinson JD, American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Radiolo (2013) Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation 128(19):e394. doi:10.​1161/​CIR.​0b013e3182a88099​ CrossRef
2.
Zurück zum Zitat Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stoval M, Donaldson SS, Green DM, Sklar CA, Robinson LL, Leisenring WM (2009) Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606. doi:10.1136/bmj.b4606 CrossRefPubMedPubMedCentral Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stoval M, Donaldson SS, Green DM, Sklar CA, Robinson LL, Leisenring WM (2009) Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606. doi:10.​1136/​bmj.​b4606 CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC (2006) Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer 42:3191–3198CrossRef van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC (2006) Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer 42:3191–3198CrossRef
4.
Zurück zum Zitat Van der Pal HJ, Van Dalen EC, Kremer LC, BP J, van Leeuwen FE (2005) Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review. Cancer Treat Rev 31:173–185CrossRef Van der Pal HJ, Van Dalen EC, Kremer LC, BP J, van Leeuwen FE (2005) Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review. Cancer Treat Rev 31:173–185CrossRef
5.
Zurück zum Zitat Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, Sklar CA, Robison LL, Oeffinger KC (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the Childhood Cancer Survivor Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32:1218–1224CrossRef Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, Sklar CA, Robison LL, Oeffinger KC (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the Childhood Cancer Survivor Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32:1218–1224CrossRef
6.
Zurück zum Zitat Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27:2328–2338CrossRef Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC (2009) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27:2328–2338CrossRef
7.
Zurück zum Zitat Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, Nathan PC, Tissing WJE, Shankar S, Sieswerda E, Skinner R, Steinberger J, Van Dalen EC, Van der Pal HJ, Wallace WH, Levitt G, Kremer LC (2015) Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 16:e123–e136. doi:10.1016/S1470-2045(14)70409-7 CrossRefPubMedPubMedCentral Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, Nathan PC, Tissing WJE, Shankar S, Sieswerda E, Skinner R, Steinberger J, Van Dalen EC, Van der Pal HJ, Wallace WH, Levitt G, Kremer LC (2015) Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 16:e123–e136. doi:10.​1016/​S1470-2045(14)70409-7 CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, Gurney JG, Donaldson SS, Leisenring W, Robison LL, Oeffinger KC (2008) Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol Off J Am Soc Clin Oncol 26:4401–4409. doi:10.1200/JCO.2008.16.9607 CrossRef Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, Gurney JG, Donaldson SS, Leisenring W, Robison LL, Oeffinger KC (2008) Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol Off J Am Soc Clin Oncol 26:4401–4409. doi:10.​1200/​JCO.​2008.​16.​9607 CrossRef
13.
Zurück zum Zitat Oeffinger KC, Hudson MM, Mertens AC, SS M, Mitby PA, Eshelman-Kent DA, Ford JS, Jones JK, Kamani S, Robison LL (2011) Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer 56:818–824. doi:10.1002/pbc.22696 CrossRefPubMed Oeffinger KC, Hudson MM, Mertens AC, SS M, Mitby PA, Eshelman-Kent DA, Ford JS, Jones JK, Kamani S, Robison LL (2011) Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer 56:818–824. doi:10.​1002/​pbc.​22696 CrossRefPubMed
14.
Zurück zum Zitat Hudson MM, Leisenring W, Stratton K, Tinner N, Steen BD, Ogg S, Barnes L, Oeffinger KC, Robison LL, Cox CL (2014) Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol 10:3974–3791. doi:10.1200/JCO.2014.57.3493 CrossRef Hudson MM, Leisenring W, Stratton K, Tinner N, Steen BD, Ogg S, Barnes L, Oeffinger KC, Robison LL, Cox CL (2014) Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol 10:3974–3791. doi:10.​1200/​JCO.​2014.​57.​3493 CrossRef
15.
Zurück zum Zitat Deci EL (1980) The psychology of self-determination. Lexington Books, Lexington, MA Deci EL (1980) The psychology of self-determination. Lexington Books, Lexington, MA
16.
Zurück zum Zitat Cox CL (1982) An interaction model of client health behavior: theoretical prescription for nursing. Adv Nurs Sci 5:41–56CrossRef Cox CL (1982) An interaction model of client health behavior: theoretical prescription for nursing. Adv Nurs Sci 5:41–56CrossRef
20.
Zurück zum Zitat Williams GC, McGregor HA, Sharp D, Levesque C, Kouides RW, Ryan RM, Deci EL (2006) Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Health Psychol 25:91–101CrossRef Williams GC, McGregor HA, Sharp D, Levesque C, Kouides RW, Ryan RM, Deci EL (2006) Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Health Psychol 25:91–101CrossRef
22.
Zurück zum Zitat DiMatteo MR, Hays RD, Gritz ER, Bastani R, Crane L, Elashoff R, Ganz P, Heber D, McCarthy W, Marcus A (1993) Patient adherence to cancer control regimens: scale development and initial validation. Psychol Assess 5(1):102. doi:10.1037/1040-3590.5.1.102 CrossRef DiMatteo MR, Hays RD, Gritz ER, Bastani R, Crane L, Elashoff R, Ganz P, Heber D, McCarthy W, Marcus A (1993) Patient adherence to cancer control regimens: scale development and initial validation. Psychol Assess 5(1):102. doi:10.​1037/​1040-3590.​5.​1.​102 CrossRef
23.
Zurück zum Zitat Derogatis LR (1993) Brief symptom inventory (BSI), administration, scoring and procedure manual. National Computer Systems, Minneapolis, Minnesota Derogatis LR (1993) Brief symptom inventory (BSI), administration, scoring and procedure manual. National Computer Systems, Minneapolis, Minnesota
24.
Zurück zum Zitat Recklitis CJ, Rodriquez P (2007) Screening childhood cancer survivors with the brief symptom inventory-18: classification agreement with the symptom checklist-90-revised. Psycho-Oncology 16:429–436CrossRef Recklitis CJ, Rodriquez P (2007) Screening childhood cancer survivors with the brief symptom inventory-18: classification agreement with the symptom checklist-90-revised. Psycho-Oncology 16:429–436CrossRef
26.
Zurück zum Zitat Wagner J (2005) Development of a questionnaire to measure heart disease risk knowledge in people with diabetes: the Heart Disease Fact Questionnaire. Patient Educ Couns 58:82–87CrossRef Wagner J (2005) Development of a questionnaire to measure heart disease risk knowledge in people with diabetes: the Heart Disease Fact Questionnaire. Patient Educ Couns 58:82–87CrossRef
28.
Zurück zum Zitat Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA (2001) Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz Praventivmed 46(Suppl 1):S3–42PubMed Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA (2001) Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz Praventivmed 46(Suppl 1):S3–42PubMed
32.
Zurück zum Zitat Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM (2005) Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 43:436–444CrossRef Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM (2005) Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 43:436–444CrossRef
33.
Zurück zum Zitat Browne M, Cudeck R (1993) Alternative ways of assessing model fit. In: Bollen KA, Long JA (eds) Testing structural equation models. Sage, Newbury Park, CA, pp. 136–162 Browne M, Cudeck R (1993) Alternative ways of assessing model fit. In: Bollen KA, Long JA (eds) Testing structural equation models. Sage, Newbury Park, CA, pp. 136–162
35.
Zurück zum Zitat Bollen K (1990) Overall fit in covariance structure models: two types of sample size effects. Psychol Bull 107:256–259CrossRef Bollen K (1990) Overall fit in covariance structure models: two types of sample size effects. Psychol Bull 107:256–259CrossRef
36.
Zurück zum Zitat Yu CY, Muthen BO (2002) Evaluation of model fit indices for latent variable models with categorical and continuous outcomes. UCLA, Graduate School of Education and Information Studies, Los Angeles Yu CY, Muthen BO (2002) Evaluation of model fit indices for latent variable models with categorical and continuous outcomes. UCLA, Graduate School of Education and Information Studies, Los Angeles
37.
Zurück zum Zitat Krull KR, Brinkman TM, Li C, Armstrong GT, Ness KK, Srivastava DK, Gurney JG, Kimberg C, Krasin MJ, Pui CH, Robison LL, Hudson MM (2013) Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude Lifetime Cohort Study. J Clin Oncol 31:4407–4415CrossRef Krull KR, Brinkman TM, Li C, Armstrong GT, Ness KK, Srivastava DK, Gurney JG, Kimberg C, Krasin MJ, Pui CH, Robison LL, Hudson MM (2013) Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude Lifetime Cohort Study. J Clin Oncol 31:4407–4415CrossRef
38.
Zurück zum Zitat Williams GC, Gagné M, Ryan RM, Deci EL (2002) Facilitating autonomous motivation for smoking cessation. Health Psychol 21:40–50CrossRef Williams GC, Gagné M, Ryan RM, Deci EL (2002) Facilitating autonomous motivation for smoking cessation. Health Psychol 21:40–50CrossRef
39.
Zurück zum Zitat Henderson TO, Hlubocky FJ, Wroblewski KE, Diller L, Daugherty CK (2010) Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28:878–883. doi:10.1200/JCO.2009.25.6107 CrossRef Henderson TO, Hlubocky FJ, Wroblewski KE, Diller L, Daugherty CK (2010) Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28:878–883. doi:10.​1200/​JCO.​2009.​25.​6107 CrossRef
40.
Zurück zum Zitat Nathan PC, Daugherty CK, Wroblewski KE, Kigin ML, Stewart TV, Hlubocky FJ, Grunfeld E, Del Giudice ME, Oeffinger KC, Henderson TO (2013) Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv 7:275–282CrossRef Nathan PC, Daugherty CK, Wroblewski KE, Kigin ML, Stewart TV, Hlubocky FJ, Grunfeld E, Del Giudice ME, Oeffinger KC, Henderson TO (2013) Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv 7:275–282CrossRef
41.
Zurück zum Zitat Suh E, Daugherty CK, Wroblewski KE, Lee H, Kigin ML, Rasinski KA, Ford JS, Tonorezos ES, Nathan PC, Oeffinger KC, Henderson TO (2014) General internists’ preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med 160:11–17CrossRef Suh E, Daugherty CK, Wroblewski KE, Lee H, Kigin ML, Rasinski KA, Ford JS, Tonorezos ES, Nathan PC, Oeffinger KC, Henderson TO (2014) General internists’ preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med 160:11–17CrossRef
42.
Zurück zum Zitat Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD, Blatt J, Constine LS, Freedman ZR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM (2004) Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 22(24):4979–4990. doi:10.1200/JCO.2004.11.032 CrossRef Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD, Blatt J, Constine LS, Freedman ZR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM (2004) Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group Long-Term Follow-Up guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 22(24):4979–4990. doi:10.​1200/​JCO.​2004.​11.​032 CrossRef
Metadaten
Titel
Factors supporting cardiomyopathy screening among at-risk adult survivors of pediatric malignancies
verfasst von
Cheryl L. Cox
Liang Zhu
Rohit P. Ojha
Brenda D. Steen
Susan Ogg
Leslie L. Robison
Melissa M. Hudson
Publikationsdatum
30.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3530-6

Weitere Artikel der Ausgabe 4/2017

Supportive Care in Cancer 4/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.